![People | Pittsburgh Center for Artificial Intelligence Innovation in Medical Imaging | University of Pittsburgh | University of Pittsburgh People | Pittsburgh Center for Artificial Intelligence Innovation in Medical Imaging | University of Pittsburgh | University of Pittsburgh](https://www.aimi.pitt.edu/sites/default/files/styles/person_small/public/person-images/al-khafaji_ahmed.jpg?itok=r1jicTzT)
People | Pittsburgh Center for Artificial Intelligence Innovation in Medical Imaging | University of Pittsburgh | University of Pittsburgh
![Ioannis ZERVANTONAKIS | Professor (Assistant) | Assistant Professor in Bioengineering | University of Pittsburgh, PA | Pitt | Bioengineering Ioannis ZERVANTONAKIS | Professor (Assistant) | Assistant Professor in Bioengineering | University of Pittsburgh, PA | Pitt | Bioengineering](https://www.researchgate.net/profile/Joshua-Gamez/publication/353103256/figure/fig2/AS:1043348433432580@1625765059544/Knockdown-of-PEAK1-in-MSCs-abrogates-their-ability-to-promote-tumorigenesis-intratumoral_Q320.jpg)
Ioannis ZERVANTONAKIS | Professor (Assistant) | Assistant Professor in Bioengineering | University of Pittsburgh, PA | Pitt | Bioengineering
![Fibroblast–tumor cell signaling limits HER2 kinase therapy response via activation of MTOR and antiapoptotic pathways | PNAS Fibroblast–tumor cell signaling limits HER2 kinase therapy response via activation of MTOR and antiapoptotic pathways | PNAS](https://www.pnas.org/content/117/28/16500/F1.large.jpg)
Fibroblast–tumor cell signaling limits HER2 kinase therapy response via activation of MTOR and antiapoptotic pathways | PNAS
![People | Pittsburgh Center for Artificial Intelligence Innovation in Medical Imaging | University of Pittsburgh | University of Pittsburgh People | Pittsburgh Center for Artificial Intelligence Innovation in Medical Imaging | University of Pittsburgh | University of Pittsburgh](https://www.aimi.pitt.edu/sites/default/files/styles/person_small/public/person-images/agarwal_vikas.jpg?itok=plB8udFe)
People | Pittsburgh Center for Artificial Intelligence Innovation in Medical Imaging | University of Pittsburgh | University of Pittsburgh
![Ioannis ZERVANTONAKIS | Professor (Assistant) | Assistant Professor in Bioengineering | University of Pittsburgh, PA | Pitt | Bioengineering Ioannis ZERVANTONAKIS | Professor (Assistant) | Assistant Professor in Bioengineering | University of Pittsburgh, PA | Pitt | Bioengineering](https://www.researchgate.net/publication/352334509/figure/fig3/AS:1033827891818499@1623495185771/Rac-1-and-cdc42-small-GTPases-mediate-actin-cytoskeleton-remodelling-and-contractility-to_Q320.jpg)
Ioannis ZERVANTONAKIS | Professor (Assistant) | Assistant Professor in Bioengineering | University of Pittsburgh, PA | Pitt | Bioengineering
![Podcast: Dr. Ioannis Zervantonakis Discusses the Microenvironment of Tumors | Regenerative Medicine at the McGowan Institute Podcast: Dr. Ioannis Zervantonakis Discusses the Microenvironment of Tumors | Regenerative Medicine at the McGowan Institute](https://mirm-pitt.net/wp-content/uploads/2021/03/tme-lab-pix.jpg)
Podcast: Dr. Ioannis Zervantonakis Discusses the Microenvironment of Tumors | Regenerative Medicine at the McGowan Institute
![A SNAI2-PEAK1-INHBA stromal axis drives progression and lapatinib resistance in HER2-positive breast cancer by supporting subpopulations of tumor cells positive for antiapoptotic and stress signaling markers | Oncogene A SNAI2-PEAK1-INHBA stromal axis drives progression and lapatinib resistance in HER2-positive breast cancer by supporting subpopulations of tumor cells positive for antiapoptotic and stress signaling markers | Oncogene](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41388-021-01906-2/MediaObjects/41388_2021_1906_Fig7_HTML.png)
A SNAI2-PEAK1-INHBA stromal axis drives progression and lapatinib resistance in HER2-positive breast cancer by supporting subpopulations of tumor cells positive for antiapoptotic and stress signaling markers | Oncogene
![Bioengineering Appoints Harvard Medical School Cancer Researcher Ioannis Zervantonakis as Assistant Professor Bioengineering Appoints Harvard Medical School Cancer Researcher Ioannis Zervantonakis as Assistant Professor](https://content.presspage.com/uploads/2602/1920_zerva_home-217481.jpg?10000)
Bioengineering Appoints Harvard Medical School Cancer Researcher Ioannis Zervantonakis as Assistant Professor
![PDF) A Novel Microfluidic Platform for High-Resolution Imaging of a Three-Dimensional Cell Culture under a Controlled Hypoxic Environment PDF) A Novel Microfluidic Platform for High-Resolution Imaging of a Three-Dimensional Cell Culture under a Controlled Hypoxic Environment](https://i1.rgstatic.net/ii/profile.image/282089455931393-1444266775325_Q64/Ioannis-Zervantonakis.jpg)
PDF) A Novel Microfluidic Platform for High-Resolution Imaging of a Three-Dimensional Cell Culture under a Controlled Hypoxic Environment
![Researchers | Pittsburgh Center for Artificial Intelligence Innovation in Medical Imaging | University of Pittsburgh Researchers | Pittsburgh Center for Artificial Intelligence Innovation in Medical Imaging | University of Pittsburgh](https://www.aimi.pitt.edu/sites/default/files/styles/person_small/public/person-images/abramowitch_steven.png?itok=zH6CK8He)
Researchers | Pittsburgh Center for Artificial Intelligence Innovation in Medical Imaging | University of Pittsburgh
![A SNAI2-PEAK1-INHBA stromal axis drives progression and lapatinib resistance in HER2-positive breast cancer by supporting subpopulations of tumor cells positive for antiapoptotic and stress signaling markers | Oncogene A SNAI2-PEAK1-INHBA stromal axis drives progression and lapatinib resistance in HER2-positive breast cancer by supporting subpopulations of tumor cells positive for antiapoptotic and stress signaling markers | Oncogene](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41388-021-01906-2/MediaObjects/41388_2021_1906_Fig1_HTML.png)